UN

Uni-Bio Science Group Ltd

Biopharmaceutical company developing regenerative medicines for tissue regeneration.

690 | HKEX

Overview

Corporate Details

ISIN(s):
KYG9198H1406
LEI:
Country:
Hong Kong
Address:
N/A

Description

Uni-Bio Science Group Ltd. is a biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of innovative biological and chemical pharmaceutical products. The company specializes in regenerative medicine, with a primary focus on developing therapeutics for bone, muscle, skin, and tissue regeneration. Key application areas include osteoporosis, complex wound healing, medical aesthetics, and ocular conditions such as corneal injury and macular degeneration. The company also explores novel treatments in otolaryngology (ENT) and aesthetic skincare. Its R&D is supported by proprietary technology platforms, including an advanced microprotein manufacturing system (ECO-KSFA®) and an intelligent hydrogel platform for tissue engineering. These platforms facilitate the development of therapies utilizing growth factors and stem cell technology to address degenerative diseases and injuries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-24 07:32
Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advanci…
English 18.8 KB

Automate Your Workflow. Get a real-time feed of all Uni-Bio Science Group Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Uni-Bio Science Group Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Uni-Bio Science Group Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.